| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |